X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2520) 2520
Book Review (298) 298
Publication (231) 231
Book Chapter (17) 17
Conference Proceeding (4) 4
Book / eBook (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2354) 2354
humans (1978) 1978
animals (1184) 1184
antibody-dependent cell cytotoxicity - drug effects (1060) 1060
antibody-dependent cell cytotoxicity (847) 847
mice (716) 716
female (668) 668
killer cells, natural - immunology (580) 580
immunology (574) 574
oncology (512) 512
male (498) 498
antibody-dependent cell cytotoxicity - immunology (444) 444
cell line, tumor (369) 369
killer cells, natural - drug effects (356) 356
cytotoxicity (354) 354
immunotherapy (346) 346
adult (323) 323
cancer (321) 321
antibodies, monoclonal - pharmacology (305) 305
antibodies, monoclonal - immunology (303) 303
antibodies, monoclonal - therapeutic use (288) 288
middle aged (276) 276
monoclonal antibodies (261) 261
antibodies (248) 248
abridged index medicus (244) 244
rituximab (243) 243
adcc (230) 230
cell line (218) 218
expression (215) 215
cytotoxicity, immunologic - drug effects (212) 212
cells, cultured (205) 205
antineoplastic agents - pharmacology (202) 202
monoclonal-antibody (202) 202
tumor cells, cultured (198) 198
flow cytometry (194) 194
hematology (183) 183
antibody-dependent cell-mediated cytotoxicity (182) 182
aged (178) 178
medicine, research & experimental (177) 177
antibody-dependent cellular cytotoxicity (176) 176
lymphocytes - immunology (159) 159
neoplasms - immunology (157) 157
lymphocyte activation - drug effects (153) 153
health aspects (151) 151
immunoglobulin g - immunology (150) 150
research (150) 150
t-lymphocytes - immunology (149) 149
in-vivo (148) 148
monocytes - immunology (146) 146
monoclonal-antibodies (141) 141
xenograft model antitumor assays (141) 141
neutrophils - immunology (140) 140
therapy (140) 140
cells (137) 137
macrophages - immunology (137) 137
mice, inbred balb c (135) 135
proteins (134) 134
rats (133) 133
activation (130) 130
analysis (130) 130
immunoglobulin g (130) 130
natural killer cells (128) 128
tumors (128) 128
cytotoxicity, immunologic (127) 127
apoptosis (126) 126
natural-killer-cells (124) 124
in vitro techniques (122) 122
article (119) 119
trastuzumab (119) 119
viral antibodies (118) 118
cell biology (117) 117
chronic lymphocytic-leukemia (117) 117
care and treatment (116) 116
dependent cellular cytotoxicity (115) 115
interleukin-2 - pharmacology (115) 115
in-vitro (113) 113
lymphocytes (113) 113
antineoplastic agents - therapeutic use (111) 111
receptors, igg - immunology (111) 111
antigens (109) 109
mice, scid (109) 109
time factors (109) 109
dose-response relationship, drug (108) 108
nk cells (106) 106
toxicity (106) 106
antibodies, monoclonal, humanized (105) 105
immunoglobulins (105) 105
pharmacology & pharmacy (105) 105
disease models, animal (103) 103
killer cells, natural - metabolism (100) 100
apoptosis - drug effects (99) 99
receptors, igg - metabolism (99) 99
antibody (97) 97
monoclonal antibody (97) 97
killer cells (95) 95
chemotherapy (94) 94
complement system proteins - immunology (94) 94
cell proliferation - drug effects (92) 92
binding (91) 91
t-cells (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2434) 2434
Japanese (28) 28
German (20) 20
Russian (16) 16
Chinese (11) 11
French (7) 7
Hungarian (4) 4
Spanish (4) 4
Bulgarian (2) 2
Italian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2014, Volume 111, Issue 17, pp. 6425 - 6430
Tetherin is an IFN-inducible transmembrane protein that inhibits the detachment of enveloped viruses from infected cells. HIV-1 overcomes this restriction... 
T lymphocytes | Antibody dependent cell cytotoxicity | Virions | Cell lines | Antivirals | Antibodies | Small interfering RNA | Viruses | Natural killer cells | HIV 1 | BST-2 | AIDS | Lentivirus | CD317 | INHIBITS HIV-1 | ASSAY | MECHANISM | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | MEMBRANE-PROTEIN | RESTRICTION | RELEASE | IN-VITRO | IMMUNODEFICIENCY-VIRUS TYPE-1 | DEGRADATION | lentivirus | Interferon-alpha - pharmacology | RNA Interference - drug effects | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Receptors, Cell Surface - metabolism | GPI-Linked Proteins - metabolism | Viral Regulatory and Accessory Proteins - metabolism | Antigens, CD - metabolism | Human Immunodeficiency Virus Proteins - metabolism | HIV Infections - immunology | HIV Infections - pathology | Signaling Lymphocytic Activation Molecule Family Member 1 | Gene Deletion | Cytoprotection - drug effects | Antibody-Dependent Cell Cytotoxicity - drug effects | GPI-Linked Proteins - antagonists & inhibitors | Amino Acid Substitution | CD4 Antigens - metabolism | Host-parasite relationships | Physiological aspects | Interferon | Research | Virus research | Health aspects | HIV infection | Membranes | Immunology | RNA-protein interactions | Human immunodeficiency virus--HIV | Cytotoxicity | Mutation | Index Medicus | Biological Sciences
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 3016 - 3026
Myelodysplastic syndromes (MDS) are stem cell disorders that can progress to acute myeloid leukemia. Although hematopoietic cell transplantation can be... 
B-LINEAGE | MYELODYSPLASTIC SYNDROME MDS | DENDRITIC CELLS | IMMUNE SUPPRESSION | FREE SURVIVAL | ACUTE LYMPHOBLASTIC-LEUKEMIA | REGULATORY T-CELLS | ANTIBODY BLINATUMOMAB | SUPPRESSOR-CELLS | MYELOID CELLS | HEMATOLOGY | Tumor Necrosis Factor-alpha - metabolism | Humans | Middle Aged | Sialic Acid Binding Ig-like Lectin 3 - immunology | Antibody-Dependent Cell Cytotoxicity - immunology | Male | Interferon-gamma - metabolism | Myelodysplastic Syndromes - prevention & control | Young Adult | Lymphocyte Activation - immunology | Flow Cytometry | Myeloid Cells - immunology | Tumor Necrosis Factor-alpha - immunology | Aged, 80 and over | Killer Cells, Natural - immunology | Adult | Female | Myeloid Cells - drug effects | Immunosuppressive Agents - pharmacology | Myelodysplastic Syndromes - metabolism | Antibodies, Bispecific - pharmacology | Cells, Cultured | Receptors, IgG - immunology | Antibodies, Bispecific - immunology | Immunosuppressive Agents - immunology | Lymphocyte Activation - drug effects | Interferon-gamma - immunology | HL-60 Cells | Lymphocyte Count | Myeloid Cells - metabolism | Aged | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Antibody-Dependent Cell Cytotoxicity - drug effects | Myelodysplastic Syndromes - immunology | Index Medicus | Abridged Index Medicus | Myeloid Neoplasia
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 18, pp. 3160 - 3164
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2008, Volume 112, Issue 13, pp. 5180 - 5189
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2018, Volume 115, Issue 46, pp. E10915 - E10924
The goal of cancer immunotherapy is to stimulate the host immune system to attack malignant cells. Antibody-dependent cellular cytotoxicity (ADCC) is a pivotal... 
interleukin-15 | macrophages | NK cells | antibody-dependent cellular cytotoxicity | cancer immunotherapy | NATURAL-KILLER-CELLS | FC-GAMMA-RIV | MULTIDISCIPLINARY SCIENCES | MONOCLONAL-ANTIBODY | ANTITUMOR-ACTIVITY | RECEPTOR ENGAGEMENT DRIVES | BETA-CHAIN | MURINE MODEL | ANTI-CD40 ANTIBODY | GROWTH-FACTOR | THERAPEUTIC ACTIVITY | Interleukin-15 - administration & dosage | Alemtuzumab - administration & dosage | Humans | Mice, Inbred C57BL | Antibody-Dependent Cell Cytotoxicity - immunology | Male | Mice, SCID | Interleukin-15 - immunology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Rituximab - administration & dosage | Animals | Cell Line, Tumor | Killer Cells, Natural - immunology | Female | Macrophages - drug effects | Mice, Inbred NOD | Killer Cells, Natural - drug effects | Mice | Antibody-Dependent Cell Cytotoxicity - drug effects | Antibodies, Monoclonal - immunology | Macrophages - immunology | Viral antibodies | Killer cells | Care and treatment | Immunotherapy | Physiological aspects | Antibodies | Interleukin-15 | Macrophages | Methods | Cancer | Adult T cell leukemia | Animal models | Toxicity | Leukemia | Xenotransplantation | Clinical trials | Cytotoxicity | Activation | Malignancy | Lymphocytes T | Metastases | Infusion | Cell activation | Lymphocytes | Xenografts | Natural killer cells | Immune system | Medical research | Cytokines | Rituximab | Interleukin 15 | Lymphoma | Cells | Effectors | Monoclonal antibodies | CD20 antigen | Antitumor activity | Tumors | Index Medicus | Biological Sciences | PNAS Plus
Journal Article